No Level 4 CDC Travel Health Notices currently exist, as official monitoring shows only Level 3 advisories for Ebola in the Democratic Republic of the Congo and Level 2 notices for malaria in Mayotte plus recent Ebola cases in Uganda. Measles outbreaks in the U.S. have produced nearly 2,000 confirmed cases through May 2026, yet remain below thresholds requiring extreme travel restrictions. Diphtheria and dengue activity in Africa and elsewhere stays at Level 1 or 2, reflecting contained transmission without the extreme health risks that historically trigger “Avoid All Travel” designations. Surveillance data through early June 2026 indicate stable conditions unlikely to escalate rapidly enough for a new Level 4 notice by year-end.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,848 Обс.
$71,848 Обс.
Dec 31, 2026
$71,848 Обс.
$71,848 Обс.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No Level 4 CDC Travel Health Notices currently exist, as official monitoring shows only Level 3 advisories for Ebola in the Democratic Republic of the Congo and Level 2 notices for malaria in Mayotte plus recent Ebola cases in Uganda. Measles outbreaks in the U.S. have produced nearly 2,000 confirmed cases through May 2026, yet remain below thresholds requiring extreme travel restrictions. Diphtheria and dengue activity in Africa and elsewhere stays at Level 1 or 2, reflecting contained transmission without the extreme health risks that historically trigger “Avoid All Travel” designations. Surveillance data through early June 2026 indicate stable conditions unlikely to escalate rapidly enough for a new Level 4 notice by year-end.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Ринок відкрито: Jan 19, 2026, 3:15 PM ET
Обсяг
$71,848Дата завершення
Dec 31, 2026Ринок відкрито
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No Level 4 CDC Travel Health Notices currently exist, as official monitoring shows only Level 3 advisories for Ebola in the Democratic Republic of the Congo and Level 2 notices for malaria in Mayotte plus recent Ebola cases in Uganda. Measles outbreaks in the U.S. have produced nearly 2,000 confirmed cases through May 2026, yet remain below thresholds requiring extreme travel restrictions. Diphtheria and dengue activity in Africa and elsewhere stays at Level 1 or 2, reflecting contained transmission without the extreme health risks that historically trigger “Avoid All Travel” designations. Surveillance data through early June 2026 indicate stable conditions unlikely to escalate rapidly enough for a new Level 4 notice by year-end.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Обсяг
$71,848Дата завершення
Dec 31, 2026Ринок відкрито
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...No Level 4 CDC Travel Health Notices currently exist, as official monitoring shows only Level 3 advisories for Ebola in the Democratic Republic of the Congo and Level 2 notices for malaria in Mayotte plus recent Ebola cases in Uganda. Measles outbreaks in the U.S. have produced nearly 2,000 confirmed cases through May 2026, yet remain below thresholds requiring extreme travel restrictions. Diphtheria and dengue activity in Africa and elsewhere stays at Level 1 or 2, reflecting contained transmission without the extreme health risks that historically trigger “Avoid All Travel” designations. Surveillance data through early June 2026 indicate stable conditions unlikely to escalate rapidly enough for a new Level 4 notice by year-end.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання